Richardson, Tim
ORCID: 0009-0006-3588-6376, Schütte, Daniel
ORCID: 0000-0002-4746-537X, Kobbe, Guido, Baermann, Ben-Niklas, Holderried, Tobias A. W.
ORCID: 0000-0002-2474-523X, Schmitz, Friederike
ORCID: 0000-0002-5271-1088, Crysandt, Martina, Hallek, Michael
ORCID: 0000-0002-7425-4455, Scheid, Christoph
ORCID: 0009-0007-6539-226X, Holtick, Udo
ORCID: 0000-0002-5543-0257, Cornely, Oliver A.
ORCID: 0000-0001-9599-3137, Stemler, Jannik
ORCID: 0000-0001-9152-2469 and Mellinghoff, Sibylle C.
ORCID: 0000-0003-3928-2503
(2025).
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis.
Blood Advances, 9 (6).
pp. 1370-1375.
Elsevier.
ISSN 2473-9529
Richardson, Tim
ORCID: 0009-0006-3588-6376, Tharmaseelan, Hishan
ORCID: 0009-0002-5680-8714, Kobbe, Guido
ORCID: 0000-0002-9745-8813, Baermann, Ben‐Niklas
ORCID: 0009-0000-1699-9478, Holderried, Tobias A. W.
ORCID: 0000-0002-2474-523X, Schmitz, Friederike
ORCID: 0000-0002-5271-1088, Crysandt, Martina
ORCID: 0000-0002-7450-3394, Gödel, Philipp
ORCID: 0000-0001-7887-8313, Wolfensberger, Nathan, Schütte, Daniel, Hallek, Michael
ORCID: 0000-0002-7425-4455, Scheid, Christof
ORCID: 0009-0007-6539-226X and Holtick, Udo
ORCID: 0000-0002-5543-0257
(2025).
Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells.
eJHaem, 6 (5).
pp. 1-5.
Wiley.
ISSN 2688-6146
Up a level